Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - EMULSION;INTRAVENOUS - 125MG/250ML (...DOSAGE - EMULSION;INTRAVENOUS - 125MG/250ML (0.5MG/ML)
USFDA APPLICATION NUMBER - 22156
DOSAGE - EMULSION;INTRAVENOUS - 25MG/50ML (0....DOSAGE - EMULSION;INTRAVENOUS - 25MG/50ML (0.5MG/ML)
USFDA APPLICATION NUMBER - 22156
DOSAGE - EMULSION;INTRAVENOUS - 50MG/100ML (0...DOSAGE - EMULSION;INTRAVENOUS - 50MG/100ML (0.5MG/ML)
USFDA APPLICATION NUMBER - 22156
Related Excipient Companies
Kewpie Corporation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Emulsifying Agents
Solubilizers
Topical
Controlled & Modified Release
Film Formers & Plasticizers
Coating Systems & Additives
Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Clevidipine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clevidipine, including repackagers and relabelers. The FDA regulates Clevidipine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clevidipine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clevidipine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clevidipine supplier is an individual or a company that provides Clevidipine active pharmaceutical ingredient (API) or Clevidipine finished formulations upon request. The Clevidipine suppliers may include Clevidipine API manufacturers, exporters, distributors and traders.
click here to find a list of Clevidipine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clevidipine DMF (Drug Master File) is a document detailing the whole manufacturing process of Clevidipine active pharmaceutical ingredient (API) in detail. Different forms of Clevidipine DMFs exist exist since differing nations have different regulations, such as Clevidipine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clevidipine DMF submitted to regulatory agencies in the US is known as a USDMF. Clevidipine USDMF includes data on Clevidipine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clevidipine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Clevidipine suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clevidipine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clevidipine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clevidipine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clevidipine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clevidipine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clevidipine suppliers with NDC on PharmaCompass.
Clevidipine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clevidipine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clevidipine GMP manufacturer or Clevidipine GMP API supplier for your needs.
A Clevidipine CoA (Certificate of Analysis) is a formal document that attests to Clevidipine's compliance with Clevidipine specifications and serves as a tool for batch-level quality control.
Clevidipine CoA mostly includes findings from lab analyses of a specific batch. For each Clevidipine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clevidipine may be tested according to a variety of international standards, such as European Pharmacopoeia (Clevidipine EP), Clevidipine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clevidipine USP).
LOOKING FOR A SUPPLIER?
Inke S.A: APIs manufacturing plant.
